Session 1 - Intro and Pharmacokinetic concepts Flashcards

1
Q

What instance would require brand prescription over generic prescription?

A

When bioavailability of drugs differs significantly.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is a black triangle drug?

A

Drug being intensively monitored for adverse effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is pharmacokinetics?

A

What body does to drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is pharmacodynamics?

A

What drug does to the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is pharmacogenetics?

A

Effect of genetic variability on pharmacokinetics of a drug on an individual

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the 4 pharmacokinetic processes?

A

ADME

Absorption, Distribution, Metabolism, Elimination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is bioavailability?

A

Fraction of a dose which finds its way into the circulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the bioavailability percentage of IV infusions?

A

100%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

In this picture, how would you calculate the total drug exposure? How would you calculate oral bioavailability?

A

Area under the curve = total drug exposure

Oral bioavailability = AUC oral / AUC iv

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What 5 factors affect the bioavailability of a drug?

A
  1. Drug formulation
  2. Age
  3. Food - lipid soluble or water soluble drug
  4. Vomiting or malabsorption
  5. First pass effect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the advantage of modified release over immediate release drug?

A

modified release spends more time in the therapeutic window than immediate release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What circulation proteins do these drugs bind to:

a) acidic drugs
b) basic drugs
c) hormones

A

a) albumin
b) lipoproteins and/or acid glycoproteins
c) globulins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What 4 factors affect protein binding of drugs?

A
  1. Hypoalbuminaema
  2. pregnancy
  3. renal failure
  4. displacement by other drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How does protein binding displacement by drug B affect drug A which is usually bound to the protein?

A

Preferential binding of protein to drug B means drug A is displaced and results in greater concentration of drug A in plasma, can have serious consequences.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How are drugs differently distributed in the body?

A

Some drugs bound to tissues, others remain only in circulation AKA volume of distribution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How does volume of distribution relate to half life?

A

Larger volume of distribution means longer half life because drug resides in tissues and has to diffuse into plasma to be eliminated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How many half lives does it take for a drug to reach steady state?

A

4-5 half lives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What 3 processes determine renal excretion of drugs?

A
  1. Glomerular filtration
  2. passive tubular reabsorption
  3. active tubular secretion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How does reduced GFR affect clearance rate of drugs?

A

Reduced GFR results in reduced clearance which increases half life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Explain zero order and first order kinetics

A

First order - Half lives. Most drugs display first order kinetics unless high doses are given in which case they display zero order

Zero order - Set amount of drug eliminated per unit time.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Which drugs are more likely to be toxic? first order or zero order and why?

A

zero order as it has a fixed rate of elimination. Small dose changes can lead to toxicity and large increments in dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

limitations of phase 1 to 3 trials

A

small number of patients, controlled nature of trials, exclusion of patients at greater risk of ADRs

23
Q

Freq of adverse events of v common, common, uncommon, rare, v rare

A

v common - 10

common - 100 then goes up in x10

24
Q

ADR types A to E

A

A - causally related to drug pharmacology. common

B - idiosyncratic response. rare

C - chronic

D - delayed e.g. steroid and osteoporosis

E - end of treatment effects

25
When should ADRs be reported via yellow card scheme?
All ADRs - if associated with new med (black triangle) or with child (below 18) or pregnent established drug - serious illnesses or death
26
Pros and cons of yellow card scheme
pros - low cost, generates ADR hypothesis cons - poor compliance, absence of control groups, coincidence or causal relationship?
27
legal requirements for prescription
legible, signed and dated, 2 forms of pt ID
28
where does 1st pass metabolism occur
gut wall, lumen, liver
29
CYP inhibitors
G-COMICS Grapefruit - cranberry, omeprazole, metronidazole, isoniazide, cimetidine, sodium valproate
30
how is T1/2 differnet in children
longer as Vd is lower as more of their body is ECF
31
Monophasic and multiphasic COCP?
monophasic - same dose of oest and prog on each of 21 days
32
COCP ADRs
increase risk of PE, stroke, DVT, headache, depression decrease risk of ovarian cancer, endometrial and colorectal
33
high ldl effects on blood?
increase platelet aggreg therefore atherogenic
34
obesity effects on lipids in blod
increase cholesterol and TG, decrease HDL
35
why acei different in blacks and older ppl
dye to reduced RAS activity
36
what is type A and B ADR according to pharmacogenetics
A - polymorphism in affected structure increase or decrease effect B - presence of gene leads to abnormal interaction e.g. hepatic porphyria induced by alcohol
37
MoA of corticosteroids
binds with intracellular receptor and complex forms dimer with another one then binds to clucocorticoid response element (GRE) in nucleus and modulats transcription
38
effects of glucocorticoids (GC) and in excess
increase blood glucose, AAs, and TGs excess - atrophy, increase bone resorption (osteoporosis), DM (prolonged increase glucose)
39
how are GCs elminated in liver what is steroid sparing drug how monitor steroid usage
phase 1 and 2 DMARD peak flow, ALT, CRP
40
how should GCs be stopped?
gradually tapered off to prevent adrenal insufficiency
41
symptoms of mineralocorticoud deficiency?
hy[ptension, dehydration, hypoNa, hyper K+
42
what is time dependent and conc dependent killing
time dependent - requires drug exceed a certain conc for a prolonged period of time to work conc dependent - needs to exceed certain conc to kill bacteria
43
severe asthma and life threatening asthma criteria
severe - unable to complete sentences, HR 110+, RR 25+, PEFR 33-55% of best life threatejning - less than 33% PEFR
44
how treat acute asthma
O2, nebulised salbutamol, oral prednisolone
45
what is autacoid and eg.
ocal hormones e.g. No, histamine
46
schedule 2 and 5 drugs
2 - storage and locked, prescription and destruction conditions 5 - just keep invoice of prescription
47
difference unfractionated and LMWH
unfractionated more effective but needs more monitoring. APTT monitor
48
nephrotoxic drugs
ACEi, NSAIDs, metformin, aminoglycosides MANA
49
ADRs of aspirin
ASPIRIN asthma, salicyalism, peptic ulcer disease, intestinal bleeding, reyes syndrome, idiosyncracy, noise (tinnititus)
50
parkinson drugs
SALAD - selegeline, anticholinergics, L-DOPA + DCT, amantadine, dopamine agonist
51
sodium valproate ADR
VALPROATE vomiting, alopecia, liver toxic, pancytopenia, retention of fats (weight gain), oedema, appetite increase, teratogen, enzyme inducer
52
steroid ADRs
CUSHINGOID cataracts, ulcers, skin straie, hypertension and hyperglyc, infections, n.., g..,osteoporosis + obesity, immunosuppression, diabetes + depression
53
WPW pathophysiology
reentry through bundle of kent